🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This multicenter, open-label, Phase I study will evaluate the safety, effic...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2015-07-22
Trial ID
NCT02431208
The purpose of the Phase 1 part of the study is to determine the maximum to...
Status
Terminated
Location
California Cancer Associates For Research and Exellence, cCare
Start Date
2014-07-30
Trial ID
NCT01999335
Treatments Being Tested
This study is determining whether the addition of cyclophosphamide to pomal...
Status
Active Not Recruiting
Location
Belfast Health & Social Care Trust
Start Date
2016-03
Trial ID
NCT02406222
Treatments Being Tested
This research is being done to test whether the investigational drug marizo...
Status
Withdrawn
Location
Massachusetts General Hospital Cancer Center
Start Date
2024-03
Trial ID
NCT05050305
Treatments Being Tested
This study aims to assess the efficacy and safety of pomalidomide in combin...
Status
Unknown
Location
Blood Diseases Hospital Chinese Academy of Medical Sciences
Start Date
2016-09
Trial ID
NCT02916420
Treatments Being Tested
This phase II trial studies how well leflunomide, pomalidomide, and dexamet...
Status
Recruiting
Location
City of Hope Medical Center
Start Date
2020-11-24
Trial ID
NCT04508790
Treatments Being Tested
This is a Phase I/II study using the combination of twice weekly ixazomib p...
Status
Active Not Recruiting
Location
Dana Farber Cancer Institute
Start Date
2019-09-18
Trial ID
NCT04094961
Treatments Being Tested
The purpose of this study is to compare the efficacy of ciltacabtagene auto...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Start Date
2020-06-12
Trial ID
NCT04181827
Treatments Being Tested
The purpose of this study is to determine the tolerated dose of pomalidomid...
Status
Completed
Location
Nagoya City University Hospital
Start Date
2012-04-01
Trial ID
NCT01568294
Treatments Being Tested
Primary Objectives: * To evaluate the safety and tolerability of isatuxima...
Status
Completed
Location
~Banner MD Anderson Cancer Center Site Number : 8400005
Start Date
2019-08-06
Trial ID
NCT04045795